Literature DB >> 19198940

The association between depressive symptoms and acute exacerbations of COPD.

Jeffrey H Jennings1, Bruno Digiovine, Dany Obeid, Cathy Frank.   

Abstract

BACKGROUND: Depression is an important comorbidity for patients with chronic obstructive pulmonary disease (COPD). The association between depression and acute exacerbations of COPD is unknown. This study was designed to determine the frequency of COPD exacerbations in outpatients with and without depressive symptoms.
METHODS: In this retrospective cohort study, patients with a primary diagnosis of COPD were followed for 1 year after discharge from a pulmonary rehabilitation program and the frequency of exacerbations was recorded. Upon completion of the program, all patients were administered the Short-Form 36 Health Survey (SF-36), which contains a mental health domain. Patients were classified as having depressive symptoms based on their domain score, which was separately validated in a second population of patients.
RESULTS: Of the 194 patients with COPD who completed the pulmonary rehabilitation program, 32 (16.5%) had depressive symptoms. There were no differences in terms of age, race, pack-years, forced expiratory volume in 1 second (FEV(1)), 6-minute walk distance, body mass index, use of supplemental oxygen, use of inhaled steroids, or the Charlson Comorbidity Index between patients with and without depressive symptoms. Patients with depressive symptoms had more exacerbations in the following year (1.91 vs. 1.36; p = 0.02), were 2.8 times more likely to have ever had an exacerbation (95% confidence interval (CI), 1.1-7.3; p = 0.03), and suffered a first exacerbation earlier (148 days compared with 266 days; p = 0.04) than nondepressed patients.
CONCLUSIONS: COPD patients with depressive symptoms have a significantly higher risk for exacerbations. Early screening for depression in patients with COPD may help identify those patients at higher risk for subsequent exacerbations.

Entities:  

Mesh:

Year:  2009        PMID: 19198940     DOI: 10.1007/s00408-009-9135-9

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  54 in total

1.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors:  P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal:  BMJ       Date:  2000-05-13

2.  Progression to AIDS: the effects of stress, depressive symptoms, and social support.

Authors:  J Leserman; E D Jackson; J M Petitto; R N Golden; S G Silva; D O Perkins; J Cai; J D Folds; D L Evans
Journal:  Psychosom Med       Date:  1999 May-Jun       Impact factor: 4.312

3.  Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.

Authors:  M Miravitlles; C Espinosa; E Fernández-Laso; J A Martos; J A Maldonado; M Gallego
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

4.  Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire.

Authors:  A M Yohannes; R C Baldwin; M J Connolly
Journal:  Int J Geriatr Psychiatry       Date:  2000-12       Impact factor: 3.485

5.  Sex differences in severe pulmonary emphysema.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Frank Sciurba; Jeanette Mumford; Nicholas D Giardino; Gail Weinmann; Ella Kazerooni; Susan Murray; Gerard J Criner; Donald D Sin; James Hogg; Andrew L Ries; MeiLan Han; Alfred P Fishman; Barry Make; Eric A Hoffman; Zab Mohsenifar; Robert Wise
Journal:  Am J Respir Crit Care Med       Date:  2007-04-12       Impact factor: 21.405

6.  Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

Authors:  Lucile Capuron; Jane F Gumnick; Dominique L Musselman; David H Lawson; Andrea Reemsnyder; Charles B Nemeroff; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2002-05       Impact factor: 7.853

Review 7.  Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review.

Authors:  L van Ede; C J Yzermans; H J Brouwer
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

8.  Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patients.

Authors:  N H Chavannes; M J H Huibers; T R J Schermer; A Hendriks; C van Weel; E F M Wouters; C P van Schayck
Journal:  Fam Pract       Date:  2005-07-15       Impact factor: 2.267

Review 9.  HIV disease progression: depression, stress, and possible mechanisms.

Authors:  Jane Leserman
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

10.  Depressive symptoms and CD4 lymphocyte decline among HIV-infected men.

Authors:  J H Burack; D C Barrett; R D Stall; M A Chesney; M L Ekstrand; T J Coates
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

View more
  35 in total

1.  Adherence and healthcare utilization among older adults with COPD and depression.

Authors:  Jennifer S Albrecht; Bilal Khokhar; Ting-Ying Huang; Yu-Jung Wei; Ilene Harris; Patience Moyo; Peter Hur; Susan W Lehmann; Giora Netzer; Linda Simoni-Wastila
Journal:  Respir Med       Date:  2017-06-03       Impact factor: 3.415

2.  Chronic obstructive pulmonary disease phenotypes: the future of COPD.

Authors:  MeiLan K Han; Alvar Agusti; Peter M Calverley; Bartolome R Celli; Gerard Criner; Jeffrey L Curtis; Leonardo M Fabbri; Jonathan G Goldin; Paul W Jones; William Macnee; Barry J Make; Klaus F Rabe; Stephen I Rennard; Frank C Sciurba; Edwin K Silverman; Jørgen Vestbo; George R Washko; Emiel F M Wouters; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

3.  The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: A longitudinal cohort study.

Authors:  Yu-Jung Wei; Linda Simoni-Wastila; Jennifer S Albrecht; Ting-Ying Huang; Patience Moyo; Bilal Khokhar; Ilene Harris; Patricia Langenberg; Giora Netzer; Susan W Lehmann
Journal:  Int J Geriatr Psychiatry       Date:  2017-08-22       Impact factor: 3.485

4.  Untangling therapeutic ingredients of a personalized intervention for patients with depression and severe COPD.

Authors:  George S Alexopoulos; Dimitris N Kiosses; Jo Anne Sirey; Dora Kanellopoulos; Joanna K Seirup; Richard S Novitch; Samiran Ghosh; Samprit Banerjee; Patrick J Raue
Journal:  Am J Geriatr Psychiatry       Date:  2013-08-14       Impact factor: 4.105

5.  Two Interventions for PatientsWith Major Depression and Severe Chronic Obstructive Pulmonary Disease: Impact on Quality of Life.

Authors:  Danielle S Jackson; Samprit Banerjee; Jo Anne Sirey; Cristina Pollari; Nili Solomonov; Richard Novitch; Alexandra Chalfin; Yiyuan Wu; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2018-12-07       Impact factor: 4.105

6.  Overview of the Impact of Depression and Anxiety in Chronic Obstructive Pulmonary Disease.

Authors:  Josep Montserrat-Capdevila; Pere Godoy; Josep Ramon Marsal; Ferran Barbé; Josep Pifarré; Miquel Alsedà; Marta Ortega
Journal:  Lung       Date:  2016-11-29       Impact factor: 2.584

7.  New episodes of depression among Medicare beneficiaries with chronic obstructive pulmonary disease.

Authors:  Jennifer S Albrecht; Ting-Ying Huang; Yujin Park; Patricia Langenberg; Ilene Harris; Giora Netzer; Susan W Lehmann; Bilal Khokhar; Linda Simoni-Wastila
Journal:  Int J Geriatr Psychiatry       Date:  2015-08-18       Impact factor: 3.485

8.  Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease.

Authors:  Jingjing Qian; Linda Simoni-Wastila; Patricia Langenberg; Gail B Rattinger; Ilene H Zuckerman; Susan Lehmann; Michael Terrin
Journal:  J Am Geriatr Soc       Date:  2013-04-25       Impact factor: 5.562

9.  Two Interventions for Patients with Major Depression and Severe Chronic Obstructive Pulmonary Disease: Impact on Dyspnea-Related Disability.

Authors:  George S Alexopoulos; Jo Anne Sirey; Samprit Banerjee; Danielle S Jackson; Dimitris N Kiosses; Cristina Pollari; Richard S Novitch; Amanda Artis; Patrick J Raue
Journal:  Am J Geriatr Psychiatry       Date:  2017-10-10       Impact factor: 4.105

10.  Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Anand S Iyer; Surya P Bhatt; Jeffrey J Garner; J Michael Wells; Jennifer L Trevor; Neha M Patel; deNay Kirkpatrick; John C Williams; Mark T Dransfield
Journal:  Ann Am Thorac Soc       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.